Cargando…

Nectin-4 is a new histological and serological tumor associated marker for breast cancer

INTRODUCTION: Breast cancer is a complex and heterogeneous disease at the molecular level. Evolution is difficult to predict according to classical histoclinical prognostic factors. Different studies highlight the importance of large-scale molecular expression analyses to improve taxonomy of breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabre-Lafay, Stéphanie, Monville, Florence, Garrido-Urbani, Sarah, Berruyer-Pouyet, Carole, Ginestier, Christophe, Reymond, Nicolas, Finetti, Pascal, Sauvan, Richard, Adélaïde, José, Geneix, Jeannine, Lecocq, Eric, Popovici, Cornel, Dubreuil, Patrice, Viens, Patrice, Gonçalves, Anthony, Charafe-Jauffret, Emmanuelle, Jacquemier, Jocelyne, Birnbaum, Daniel, Lopez, Marc
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868744/ https://www.ncbi.nlm.nih.gov/pubmed/17474988 http://dx.doi.org/10.1186/1471-2407-7-73

Ejemplares similares

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
por: Letessier, Anne, et al.
Publicado: (2006)

Molecular characterization of breast cell lines: a tool for breast cancer studies
por: Charafe-Jauffret, E, et al.
Publicado: (2005)

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes
por: Bekhouche, Ismahane, et al.
Publicado: (2011)

Genome profiling of ERBB2-amplified breast cancers
por: Sircoulomb, Fabrice, et al.
Publicado: (2010)

Nectin-3 (CD113) Interacts with Nectin-2 (CD112) to Promote Lymphocyte Transendothelial Migration
por: Devilard, Elisabeth, et al.
Publicado: (2013)

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
por: Jacquemier, Jocelyne, et al.
Publicado: (2009)

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin
por: Ben Hamida, Azza, et al.
Publicado: (2008)

8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer
por: Bertucci, François, et al.
Publicado: (2012)

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial
por: Jacquemier, Jocelyne, et al.
Publicado: (2011)

Breast cancer stem cells: tools and models to rely on
por: Charafe-Jauffret, Emmanuelle, et al.
Publicado: (2009)

Targeting breast cancer stem cells: fishing season open!
por: Ginestier, Christophe, et al.
Publicado: (2010)

p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012)

Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
por: Cornen, Stéphanie, et al.
Publicado: (2014)

Comparative genomic analysis of primary tumors and metastases in breast cancer
por: Bertucci, François, et al.
Publicado: (2016)

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011)

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011)

MARCKS protein overexpression in inflammatory breast cancer
por: Manai, Maroua, et al.
Publicado: (2016)

Kinome expression profiling and prognosis of basal breast cancers
por: Sabatier, Renaud, et al.
Publicado: (2011)

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study
por: Gonçalves, Anthony, et al.
Publicado: (2016)

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
por: Guerin, Mathilde, et al.
Publicado: (2018)

Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer
por: Mezil, Lynda, et al.
Publicado: (2012)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014)

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2019)

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers
por: de Nonneville, Alexandre, et al.
Publicado: (2019)

Prognostic and predictive value of PDL1 expression in breast cancer
por: Sabatier, Renaud, et al.
Publicado: (2014)

Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors
por: Pastor, Sonia, et al.
Publicado: (2023)

Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib
por: Gilabert, Marine, et al.
Publicado: (2014)

HTS-Net: An integrated regulome-interactome approach for establishing network regulation models in high-throughput screenings
por: Rioualen, Claire, et al.
Publicado: (2017)

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers
por: Monneur, Audrey, et al.
Publicado: (2017)

CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
por: Guégan, Jean-Philippe, et al.
Publicado: (2021)

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.
por: Jacquemier, J., et al.
Publicado: (1994)

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
por: Bertucci, François, et al.
Publicado: (2021)

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells
por: Azzoni, Violette, et al.
Publicado: (2022)

The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling
por: Lopez Almeida, Leonor, et al.
Publicado: (2018)

Loss, mutation and deregulation of L3MBTL4 in breast cancers
por: Addou-Klouche, Lynda, et al.
Publicado: (2010)

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy
por: Bertucci, François, et al.
Publicado: (2015)

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
por: Zabouo, Gwladys, et al.
Publicado: (2009)

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007)

Tracing the evolution of nectin and nectin-like cell adhesion molecules
por: Duraivelan, Kheerthana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekctpp9n4q3e1aej0l15embaq3